Intervention Review

You have free access to this content

Selective serotonin reuptake inhibitors for premenstrual syndrome

  1. Jane Marjoribanks1,
  2. Julie Brown1,*,
  3. Patrick Michael Shaughn O'Brien2,
  4. Katrina Wyatt3

Editorial Group: Cochrane Gynaecology and Fertility Group

Published Online: 7 JUN 2013

Assessed as up-to-date: 11 FEB 2013

DOI: 10.1002/14651858.CD001396.pub3

How to Cite

Marjoribanks J, Brown J, O'Brien PMS, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD001396. DOI: 10.1002/14651858.CD001396.pub3.

Author Information

  1. 1

    University of Auckland, Obstetrics and Gynaecology, Auckland, New Zealand

  2. 2

    Keele University Medical School, Academic Department of Obstetrics and Gynaecology, Stoke-on-Trent, Staffordshire, UK

  3. 3

    Peninsula College of Medicine and Dentistry, Institute of Health Service Research, Exeter, UK

*Julie Brown, Obstetrics and Gynaecology, University of Auckland, Park Rd, Grafton, Auckland, 1003, New Zealand.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 7 JUN 2013


Cited in:


This article has been cited by:

  1. 1
    J.C. Chrisler, J.A. Gorman, Encyclopedia of Mental Health, 2016,


  2. 2
    Hamed Fanaei, Samira Khayat, Amir Kasaeian, Mani Javadimehr, Effect of curcumin on serum brain-derived neurotrophic factor levels in women with premenstrual syndrome: A randomized, double-blind, placebo-controlled trial, Neuropeptides, 2015,


  3. 3
    Adam J. Devall, Julia M. Santos, Jonathan P. Fry, John W. Honour, Marcus L. Brandão, Thelma A. Lovick, Elevation of brain allopregnanolone rather than 5-HT release by short term, low dose fluoxetine treatment prevents the estrous cycle-linked increase in stress sensitivity in female rats, European Neuropsychopharmacology, 2015, 25, 1, 113


  4. 4
    Ginger Evans, Eliza L. Sutton, Oral Contraception, Medical Clinics of North America, 2015, 99, 3, 479


  5. 5
    Aeli Ryu, Tae-Hee Kim, Premenstrual syndrome: A mini review, Maturitas, 2015, 82, 4, 436


  6. 6
    J P Fry, K Y Li, A J Devall, S Cockcroft, J W Honour, T A Lovick, Fluoxetine elevates allopregnanolone in female rat brain but inhibits a steroid microsomal dehydrogenase rather than activating an aldo-keto reductase, British Journal of Pharmacology, 2014, 171, 24
  7. 7
    Charalampos Siristatidis, In women with premenstrual syndrome, what are the benefits and harms of selective serotonin reuptake inhibitors?, Cochrane Clinical Answers,